StockData
Longeveron Inc. logo

Longeveron Inc. (LGVN) shareholders

LGVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.92−0.19 (-9.00%)

Close on Nov 18, 2026Market cap $61.21MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
1.5%
0M of 32M shares
Institutional holders
39
14 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Intracoastal Capital LLC
Joint filing with Mitchell P. Kopin (9.00%), Daniel B. Asher (9.00%)
2,941,1809.00%13G (passive) amendmentJun 30, 2026
Mitchell P. Kopin
Joint filing with Daniel B. Asher (9.99%), Intracoastal Capital LLC (9.99%)
2,143,4189.99%13G (passive)Aug 8, 2025
Millennium Management LLC
Joint filing with Integrated Core Strategies (US) LLC (5.20%), Millennium Group Management LLC (5.20%) and 1 more
1,553,6425.20%13G (passive)Aug 4, 2026
Janus Henderson Group PLC1,291,3315.90%13G (passive)Mar 31, 2026
Joshua M. Hare, M.D1,084,88825.70%13D (active) amendmentApr 10, 2024
Logos Global Management GP LLC
Joint filing with Logos Global Management LP (6.30%), Logos Opportunities Fund V LP (6.30%) and 3 more
192,3086.30%13G (passive)Sep 2, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of LGVNValueChange% of portfolio
Millennium Management LLC135,3880.42%$951.78K+90,7150.00%
Logos Global Management LP128,7000.40%$904.76KNew0.04%
Vanguard Capital Management LLC58,1310.18%$408.66K+3,9280.00%
BlackRock, Inc.22,4170.07%$157.59K−30.00%
Geode Capital Management, LLC20,3760.06%$143.24K+140.00%
Jane Street Group, LLC19,0370.06%$133.83K+4710.00%
Vanguard Fiduciary Trust Co14,0130.04%$98.51K+10,1410.00%
Mariner, LLC12,6000.04%$88.58KNew0.00%
ADAR1 Capital Management, LLC10,8410.03%$76.21K−9,1590.00%
Beacon Pointe Advisors, LLC10,0000.03%$70.30K–0.00%
Virtu Financial LLC5,8580.02%$41.00KNew0.00%
Two Sigma Securities, LLC5,5970.02%$39.35KNew0.00%
State Street Corp4,5380.01%$31.90K–0.00%
Northern Trust Corp4,3300.01%$30.44K+2,3520.00%
Scotia Capital Inc.3,0000.01%$21.09KNew0.00%
Capital Investment Advisory Services, LLC2,6530.01%$18.65K–0.00%
Commonwealth Equity Services, LLC2,5160.01%$17.68K–0.00%
Hamilton Point Investment Advisors, LLC2,2450.01%$15.78K–0.00%
Moneta Group Investment Advisors LLC2,1300.01%$14.97K–0.00%
XTX Topco Ltd2,0560.01%$14.45KNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026390M1.5%14 / 73 / 50M0M
Q1 2026310M0.7%11 / 33 / 90M0M
Q4 2025300M0.3%6 / 36 / 30M0M
Q3 2025270M0.3%9 / 32 / 40M0M
Q2 2025220M0.2%6 / 42 / 20M0M
Q1 2025180M0.2%2 / 45 / 60M0M
Q4 2024220M0.2%10 / 42 / 50M0M
Q3 2024170M0.1%7 / 41 / 80M0M
Q2 2024190M0.1%10 / 43 / 30M0M
Q1 2024120M0.0%12 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Joshua HareChief Scientific Officer, Director, 10% owner10,811,36933.91%Aug 21, 2026
Nirav S. JhaveriChief Financial Officer29,2580.09%Oct 5, 2026
Paul T. LehrGeneral Counsel, Secretary226,2950.71%Oct 5, 2026
Stephen H. WillardChief Executive Officer74,9160.23%Oct 5, 2026
Nataliya AgafonovaChief Medical Officer89,5640.28%Oct 5, 2026
Devin BlassCTO & SVP of CMC68,6530.22%Oct 5, 2026
Marie WashburnChief Financial Officer101,0300.32%Jul 21, 2026
Lisa LocklearChief Financial Officer480,0051.51%Jul 6, 2026
James Nathaniel PowellChief Executive Officer125,5930.39%Jan 6, 2026
Mohamed Wa'el Ahmed HashadChief Executive Officer543,5471.70%Jul 17, 2025
Roger Joseph HajjarDirector69,0000.22%Aug 21, 2026
Leah Rush CannDirector36,0000.11%Aug 21, 2026
Deborah AscheimDirector36,0000.11%Aug 21, 2026
George A. Paletta Jr.Director70,0000.22%Aug 21, 2026
Arjun JJ DesaiDirector36,0000.11%Aug 21, 2026
Ursula UngaroDirector77,0000.24%Aug 21, 2026
Rock SofferDirector964,3853.02%Aug 21, 2026
Khoso BaluchDirector67,3910.21%Aug 13, 2025
Richard N. KenderDirector33,0000.10%Jul 17, 2025
Neha J. MotwaniDirector33,0000.10%Jul 17, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Nirav S. Jhaveri
Chief Financial Officer
Oct 1, 2026Tax withholding−742$2.59$1.92K29,258
Stephen H. Willard
Chief Executive Officer
Oct 1, 2026Tax withholding−1,987$2.59$5.15K74,916
Nataliya Agafonova
Chief Medical Officer
Oct 1, 2026Tax withholding−2,913$2.59$7.54K68,778
Paul T. Lehr
General Counsel, Secretary
Oct 1, 2026Tax withholding−2,253$2.59$5.84K83,889
Devin Blass
CTO & SVP of CMC
Oct 1, 2026Tax withholding−2,520$2.59$6.53K68,653
Paul T. Lehr
General Counsel, Secretary
Aug 19, 2026Award+286,000––861,423
Joshua Hare
Chief Scientific Officer, Director, 10% owner
Aug 19, 2026Award+286,000––1,607,796
Rock Soffer
Director
Aug 19, 2026Award+36,000––262,034
Roger Joseph Hajjar
Director
Aug 19, 2026Award+36,000––69,000
Ursula Ungaro
Director
Aug 19, 2026Award+36,000––77,000
Devin Blass
CTO & SVP of CMC
Aug 19, 2026Award+286,000––711,735
Arjun JJ Desai
Director
Aug 19, 2026Award+36,000––36,000
George A. Paletta Jr.
Director
Aug 19, 2026Award+36,000––70,000
Nataliya Agafonova
Chief Medical Officer
Aug 19, 2026Award+286,000––716,914
Deborah Ascheim
Director
Aug 19, 2026Award+36,000––36,000
Leah Rush Cann
Director
Aug 19, 2026Award+36,000––36,000
Nirav S. Jhaveri
Chief Financial Officer
Aug 17, 2026Award+300,000––300,000
Joshua Hare
Chief Scientific Officer, Director, 10% owner
Jul 6, 2026Award+600,000––1,321,796
Stephen H. Willard
Chief Executive Officer
Jul 1, 2026Tax withholding−18,046$0.73$13.17K771,681
Devin Blass
CTO & SVP of CMC
Jul 1, 2026Tax withholding−15,808$0.73$11.54K425,735
Paul T. Lehr
General Counsel, Secretary
Jul 1, 2026Tax withholding−13,143$0.73$9.59K575,423
Lisa Locklear
Chief Financial Officer
Jul 1, 2026Tax withholding−22,505$0.73$16.43K443,181
Nataliya Agafonova
Chief Medical Officer
Jul 1, 2026Tax withholding−22,505$0.73$16.43K430,914
Paul T. Lehr
General Counsel, Secretary
May 1, 2026Award+250,000––588,566
Stephen H. Willard
Chief Executive Officer
May 1, 2026Award+500,000––789,727
Nataliya Agafonova
Chief Medical Officer
May 1, 2026Award+250,000––453,419
Lisa Locklear
Chief Financial Officer
May 1, 2026Award+250,000––465,686
Devin Blass
CTO & SVP of CMC
May 1, 2026Award+250,000––441,543
Nataliya Agafonova
Chief Medical Officer
Apr 1, 2026Tax withholding−13,145$1.12$14.72K203,419
Paul T. Lehr
General Counsel, Secretary
Apr 1, 2026Tax withholding−5,611$1.12$6.28K338,566
Lisa Locklear
Chief Financial Officer
Apr 1, 2026Tax withholding−13,145$1.12$14.72K215,686
Stephen H. Willard
Chief Executive Officer
Apr 1, 2026Tax withholding−4,740$1.12$5.31K289,727
Devin Blass
CTO & SVP of CMC
Apr 1, 2026Tax withholding−8,633$1.12$9.67K191,543
Stephen H. Willard
Chief Executive Officer
Mar 2, 2026Tax withholding−105,533$0.55$58.04K94,467
Stephen H. Willard
Chief Executive Officer
Mar 2, 2026Award+200,000––200,000
Stephen H. Willard
Chief Executive Officer
Mar 2, 2026Award+200,000––294,467
James Nathaniel Powell
Chief Executive Officer
Jan 2, 2026Tax withholding−2,464$0.59$1.45K125,593
Paul T. Lehr
General Counsel, Secretary
Jan 2, 2026Tax withholding−6,952$0.59$4.10K344,177
Lisa Locklear
Chief Financial Officer
Jan 2, 2026Tax withholding−10,250$0.59$6.05K228,831
Devin Blass
CTO & SVP of CMC
Jan 2, 2026Tax withholding−10,700$0.59$6.31K200,176
Nataliya Agafonova
Chief Medical Officer
Jan 2, 2026Tax withholding−10,250$0.59$6.05K216,564
George A. Paletta Jr.
Director
Oct 1, 2025Award+34,000––34,000
James Nathaniel Powell
Chief Executive Officer
Oct 1, 2025Tax withholding−2,389$0.74$1.77K128,057
Devin Blass
CTO & SVP of CMC
Oct 1, 2025Tax withholding−7,609$0.74$5.63K210,876
Nataliya Agafonova
Chief Medical Officer
Oct 1, 2025Tax withholding−11,883$0.74$8.79K226,814
Lisa Locklear
Chief Financial Officer
Oct 1, 2025Tax withholding−11,883$0.74$8.79K239,081
Paul T. Lehr
General Counsel, Secretary
Oct 1, 2025Tax withholding−4,944$0.74$3.66K351,129
James Nathaniel Powell
Chief Executive Officer
Sep 4, 2025Award+50,000––130,446
Khoso Baluch
Director
Aug 11, 2025Buy+11,766––52,516
Lisa Locklear
Chief Financial Officer
Aug 11, 2025Buy+11,766––250,964
Rock Soffer
Director
Jul 15, 2025Award+17,000––226,034
Lisa Locklear
Chief Financial Officer
Jul 15, 2025Award+102,000––239,198
Roger Joseph Hajjar
Director
Jul 15, 2025Award+17,000––33,000
Richard N. Kender
Director
Jul 15, 2025Award+17,000––33,000
Neha J. Motwani
Director
Jul 15, 2025Award+17,000––33,000
Paul T. Lehr
General Counsel, Secretary
Jul 15, 2025Award+102,000––356,073
Nataliya Agafonova
Chief Medical Officer
Jul 15, 2025Award+102,000––238,697
Ursula Ungaro
Director
Jul 15, 2025Award+17,000––41,000
Khoso Baluch
Director
Jul 15, 2025Award+17,000––40,750
Mohamed Wa'el Ahmed Hashad
Chief Executive Officer
Jul 15, 2025Award+180,000––420,904

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.88%
0M shares short
Days to cover
2.2
At 0M shares a day
Change since last report
+114.7%
From 0M shares
Short volume, 20 days
51.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Longeveron's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,970 shares on Sep 17, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Rock Soffer
Director
May 29, 202521,000$26.78KMay 29, 2025Purchase - Pre-IPO
Joshua Hare
Officer, Director
May 15, 20255,250$7.22KMay 15, 2025Founder's Equity
Khoso Baluch
Director
Nov 27, 20241,250$2.58KNov 27, 2024Open Market Purchase

See a number that looks wrong?